Status:

COMPLETED

Effect of Phytosterols on Nonalcoholic Fatty Liver Disease

Lead Sponsor:

China Medical University Hospital

Conditions:

Non-alcoholic Fatty Liver Disease

Eligibility:

All Genders

25-80 years

Phase:

NA

Brief Summary

Phytosterols are plant sterols . Phytosterols have anti-inflammation effect. Investigators have a hypothesis: phytosterols reduce oxidative stress , enhance Insulin-like growth factor-1(IGF-1) and end...

Detailed Description

Fatty liver is the hepatic feature of metabolic syndrome. Metabolic syndrome increase the risk of atherosclerosis and cardiovascular disease. Adipose tissue secrete adipocytes accumulate in the liver ...

Eligibility Criteria

Inclusion

  • (1)25-80 years
  • (2)Fatty liver was diagnosed by abdominal echo by the same gastrologist, review by another gastrologist

Exclusion

  • (1)Serological markers of hepatitis B virus(hepatitis B surface antigen and anti-HBs antibody) and hepatitis C virus infection (anti-HCV antibody)
  • (2)Autoimmune liver disease or alcoholic liver disease(alcohol intake more than 20g per day by using a questionnaire)
  • (3)Malignant diseases
  • (4)Pregnancy or breast feeding
  • (5)Clinical evidence of angina, congestive heart failure, valvular heart disease, inflammatory disease or thyroid dysfunction

Key Trial Info

Start Date :

October 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2013

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT01875978

Start Date

October 1 2012

End Date

July 1 2013

Last Update

June 11 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

China Medical University Hospital

Taichung, Taiwan